EaseMyTrip touches market cap of a billion dollars

Advertisement
EaseMyTrip touches market cap of a billion dollars
EaseMyTrip/Canva
  • The company’s stock was trading at around ₹714 in early trading hours on Friday.
  • The development comes a day after EaseMyTrip expanded its international footprint to the US, Philippines and Thailand.
  • The company had doubled its net profit to ₹61.4 crore in the financial year 2021.
Publicly-listed travel ticketing app EaseMyTrip has hit $1 billion in market capitalisation earlier on Friday, September 17.

The company’s stock was trading at ₹714.15 at 9:38 a.m., on Friday. That’s when the company’s market cap crossed the ₹7,300 crore threshold.

Shares of the travel tech startup, which goes by the name Easy Trip Planners, were trading at ₹663.55 at 11:10 a.m., on Friday as its market cap dropped to ₹7,215 crore ($981 million).

Advertisement
The development comes a day after EaseMyTrip expanded its international footprint in the United States, The Philippines and Thailand. The company has forayed into new countries anticipating a huge pent-up global travel demand in the coming months, the company said in its regulatory filings.

Aloke Bajpai, founder and chief executive of another travel tech startup ixigo, congratulated EaseMyTrip on achieving this benchmark. Like EaseMyTrip, rival ixigo is also planning to hit the public markets this year and has filed the preliminary papers for its ₹1,600 crore initial public offering (IPO).


Earlier this month, Anand Rathi had issued a buy call on Easy Trip Planners with a target price of ₹550. At the time, the company’s stock was trading at ₹462.35.
Advertisement

EaseMyTrip touches market cap of a billion dollars
BI India

Founded in 2008 by Nishant Pitti, Prashant Pitti and Rikant Pitti, EaseMyTrip offers deals on flight booking, hotels and holiday packages. The company has been one of the few bootstrapped startups to hit the public market and has been profitable as well.

The company even doubled its net profit to ₹61.4 crore in the financial year 2021, when the entire travel segment was brought down to its knees due to COVID-19. Its revenue, however, declined to ₹150 crore from ₹181 crore reported in FY20.

SEE ALSO

Advertisement
Future of Work 2021: The only way to beat the bots from taking your job is to be more human

Biocon, Hero MotoCorp, TVS Motor, banks and other top stocks to watch out for on September 17

Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion

Advertisement
{{}}